CARLSBAD, Calif., Nov. 4, 2016 /PRNewswire/ -- ALASTIN Skincare™, Inc. ( www.alastin.com) —a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products with proprietary TriHex Technology™ that enhance, protect, and maintain healthy skin for a lifetime—has announced the appointment of Bob Rhatigan to the company's Board of Directors effective December 2016. Mr. Rhatigan holds a proven track record of successful business leadership and development of leading brands in the medical aesthetics arena. He most recently served as President and Chief Operating Officer at Alphaeon Corporation, a healthcare company focused on the lifestyle medical space. Prior to this, Mr. Rhatigan spent 17 years at Allergan Inc., where he served as Senior Vice President, General Manager and Chief Executive of SkinMedica® Inc. Prior to this role, Mr. Rhatigan served as Senior Vice President of Allergan Inc.'s Facial Aesthetics business, where he led the launches and marketplace success of BOTOX® COSMETIC, JUVEDERM® and LATISSE® in the United States. "We are extremely pleased to have Bob join the ALASTIN team on our Board of Directors," said Diane S. Goostree, President and CEO of ALASTIN Skincare. "He brings an extensive track record and wealth of experience in the aesthetics space across multiple leading companies and will be a valuable advisor to us as we continue our rapid growth and evolution into a leader in the aesthetics field with our Procedure Enhancement System products and daily skin care Restore & Renew product line." "I am thrilled to have the opportunity to be part of ALASTIN Skincare's Board of Directors as the company leverages its market-disrupting technology platform to expand the physician-dispensed aesthetics industry," stated Mr. Rhatigan. "I look forward to working with the Board and Management during the rapid growth phase ahead."